Overall rank by patents
#30,003
Across all tracked assignees
USPTO PatentsView assignee record - 9 granted patents across 10 technology areas, active 2017–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).
The verdict
Servizo holds 9 US patents across 10 technology areas, rank #30,003 of 50,000 tracked assignees.
Servizo Galego DE Saúde (sergas) has been granted 9 US utility patents between 2017 and 2025, placing Servizo Galego DE Saúde (sergas) at rank #30,003 across all assignees tracked by PlainPatent. This portfolio spans 10 distinct Cooperative Patent Classification (CPC) subclasses, averaging 13.3 claims per patent with primary concentration in A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). As a Foreign Corporation, Servizo Galego DE Saúde (sergas) is one of the more focused assignees in the PatentsView dataset. By volume, Servizo sits between Senseage Co., Ltd. (9 patents, rank #29,999) and Shanghai Advanced Research Institute, Chinese Academy OF Sciences (9 patents, rank #30,007) - the closest US assignees by grant volume. The composite Innovation Score of 32.1/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 7 grants, compared with 2 in the 2015–2019 window, a +250% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Servizo Galego DE Saúde (sergas)'s 13.3 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 10 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Servizo Galego DE Saúde (sergas) against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
SENSEAGE CO., LTD.
9 patents
SENSLYTICS CORPORATION
9 patents
SENSR Monitoring Technologies LLC
9 patents
SERENE MEDICAL, INC.
9 patents
SES S.A.
9 patents
SG MICRO CORP
9 patents
SHANDONG SINOCERA FUNCTIONAL MATERIAL CO., LTD.
9 patents
SHANGHAI ADVANCED RESEARCH INSTITUTE, CHINESE ACADEMY OF SCIENCES
9 patents
SERVIZO GALEGO DE SAÚDE (SERGAS)
9 patents
What this shows Servizo holds 9 patents at rank #30,003, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #30,003 in granted patent volume.
Other assignees with the most granted patents in Servizo's primary technology class.
Servizo's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
32 Top 60% higher than 40% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 1 | 11.1% |
| 2019 | 1 | 11.1% |
| 2020 | 1 | 11.1% |
| 2021 | 2 | 22.2% |
| 2022 | 1 | 11.1% |
| 2023 | 2 | 22.2% |
| 2025 | 1 | 11.1% |
Top 10 of 10 technology areas
Overall rank by patents
#30,003
Across all tracked assignees
32.1 out of 100
How to use this portfolio
Servizo's 9 grants land it in the top 60% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.